3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Conditions
Multiple Myeloma
68
Recurrence
10
Lymphoma
7
Neoplasms, Plasma Cell
5
Waldenstrom Macroglobulinemia
4
Small Cell Lung Carcinoma
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Lymphoma, T-Cell, Peripheral
3
Lymphoma, Non-Hodgkin
3
Lymphoma, Large B-Cell, Diffuse
3
Leukemia
3
Hematologic Neoplasms
3
Ovarian Neoplasms
2
Lymphoma, T-Cell
2
Lymphoma, Mantle-Cell
2
Kidney Neoplasms
2
Disease
2
Carcinoma, Non-Small-Cell Lung
2
Uterine Cervical Neoplasms
1
Stomach Neoplasms
1
Salivary Gland Adenoma, Pleomorphic
1
Renal Insufficiency
1
Prostatic Neoplasms
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Neoplasms
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, Follicular
1
Lymphoma, Extranodal NK-T-Cell
1
Lymphoma, B-Cell, Marginal Zone
1
Leukemia, Prolymphocytic
1
Interventions
Dexamethasone
12
Melphalan
7
Calcium Dobesilate
6
Lenalidomide
5
Bortezomib
5
Cyclophosphamide
4
miridesap
3
ixazomib
2
Doxycycline
2
Biopsy
2
4-(N-methylamino)-4'-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)stilbene
2
pomalidomide
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
daratumumab
1
carfilzomib
1
birtamimab
1
auricularum
1
Vinorelbine
1
Thalidomide
1
Tacrolimus
1
Pharmaceutical Preparations
1
Interleukin-2
1
Granulocyte-Macrophage Colony-Stimulating Factor
1
Gemcitabine
1
Filgrastim
1
Etanercept
1
Drug Evaluation
1
Blood Specimen Collection
1
Bendamustine Hydrochloride
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Amyloidosis
×
carfilzomib
×
Clear all
NCT02545907
2021-04-15
CATALYST
University College, London
Phase 1/2
Completed
10 enrolled
14 charts